Growth factors such as transforming growth factor beta(TGFb), epidermal growth-factor(EGF) and fibroblast-growth-factorlike(FGF) proteins have been reported to be implicated in wound healing, tumorigenesis and embryogenesis. These proteins are capable of modulating, e.g., cellular proliferation, differentiation, migration or protein synthesis. EGF-like proteins, including EGF, TGFa, amphiregulin and heregulins (HRG), are expressed in various normal epithelial and carcinoma cells (Plowman et al., 1990;Johnson et al., 1992;Danilenko et al., 1995;Salomon et al., 1995). In several carcinomas, such as breast and renal carcinomas, over-expression of TGFa and/or amphiregulin has been observed (Mydlo et al., 1989;LeJeune et al., 1993;Salomon et al., 1995). Normal human bladder urothelium is reported to express EGF, TGFa and amphiregulin, while high levels of EGF have been found in urine of normal individuals (Kimball et al., 1984;Lau et al., 1988;Cilento et al., 1994). However, the urine of patients with transitional-cell carcinoma (TCC) contains enhanced levels of TGFa (Kimball et al., 1984). Expression of the EGF receptor (EGFR) which binds EGF, TGFa and amphiregulin, was demonstrated to be augmented in human TCCs, notably in the more aggressive TCCs (Messing et al., 1987;Neal et al., 1990). Functional effects of EGF-like proteins include stimulation of proliferation and migration of different normal epithelial and carcinoma cells, including murine urothelial cells (De Boer et al., 1993Danilenko et al., 1995). Both expression and functional data suggest a direct function for EGF-like molecules in TCC development or progression. While HRG were shown to enhance proliferation, migration or differentiation of normal skin and breast epithelial cells Marikovsky et al., 1995;Yang et al., 1995), less is known about the functions of HRG in tumour growth. The expression of their receptors, c-erbB3 (HER3) and c-erbB4 (HER4), was observed to be enhanced in several tumours, including breast and bladder carcinomas (Lemoine et al., 1992;Plowman et al., 1993;Rajkumar et al., 1996), suggesting an implication of HRG in these tumours. While c-erbB3 was also reported to be present in the normal urogenital tract, little is known about functions of HRG or their receptors in human urothelium or TCCs.FGF have also been suggested to be involved in human TCC growth. Chopin et al. (1993) demonstrated enhanced FGF-1, but not FGF-2, expression in TCCs. Furthermore, FGF-1 was shown to induce in vitro proliferation, motility and invasion of murine bladder-carcinoma cells (Vallés et al., 1990;Tucker et al., 1991;De Boer et al., 1993). These studies suggest a direct role for FGF-1 in TCC-cell invasion. Finally, mis-sense mutations in TGFb receptors(TGFbR) types I and II have been shown in colon-, gastric-and prostate-carcinoma cells (Myeroff et al., 1995;Lee et al., 1996), resulting in TGFb-non-responsive cells . Although functional TGFb receptors(TGFbR) types I and II are expressed in normal human urothelium (De Boer et al., 1996), little is known a...